Published: 2019-07-24

Seroprevalence of Hepatitis B and Hepatitis C in end-stage renal disease patients on maintenance hemodialysis: a single-center study from Bangladesh

S. M. Rahid Sarwar, A. K. M Mijanur Rahman, S. M. Mijanur Rahman, Shahjada Selim, A. B. M. Kamrul Hasan


Background: Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections are important causes of morbidity and mortality in hemodialysis (HD) patients. The aim of this study was to estimate the seroprevalence of HBV and HCV among end-stage renal disease (ESRD) patients on maintenance HD.

Methods: This cross-sectional study was conducted in the hemodialysis unit of a military hospital of Bangladesh from October 2013 to March 2014 and included 141 maintenance HD patients. All patients were assessed by HBsAg and anti-HCV antibodies in addition to routine liver function tests.

Results: The age range of the study subjects were 18-70 years, and the majority (85.11%) were male. Among them 22 (15.60%) were positive for anti HCV, 5(3.5%) were positive for HBsAg, and 3 patients (2.13%) were positive for both HBsAg and anti-HCV. The duration of hemodialysis was higher in anti-HCV positive patients (49±24 vs. 25±10 months, p <0.05) than anti-HCV negative ones. Anti-HCV positive patients in this study received a higher number of blood transfusion (units) than anti-HCV negative patients (7.5±4.3 vs. 2.8±1.7 units, p <0.05). HBsAg positive patients also received a higher number of blood transfusion (units) than HBsAg negative patients (8.2±3.1 vs. 3.2±1.2 units, p <0.05).

Conclusions: Hepatitis C virus was the major form of hepatitis in HD patients in this study. The duration of HD was higher in anti-HCV positive patients; the numbers of blood transfusion units were higher in patients positive for HCV and HBV than the negative ones.


End-stage renal disease, Hemodialysis, Hepatitis B, Hepatitis C

Full Text:



Demirtürk N, Demirdal T, Toprak D, Altindiş M, Aktepe OC. Hepatitis B and C virus in West-Central Turkey: seroprevalence in healthy individuals admitted to a university hospital for routine health checks. Turk J Gastroenterol Off J Turkish Soc Gastroenterol. 2006;17(4):267-72.

Bini EJ, Perumalswami PV. Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: Prevalence, racial/ethnic differences, and viral interactions. Hepatol. 2010;51:759-66.

Souza KP, Luz JA, Teles SA, Carneiro MA, Oliveira LA, Gomes AS, et al. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles. Memories Oswaldo Cruz Institute. 2003;98(5):599-603.

Zacks SL, Fried MW. Hepatitis B and C and renal failure. Infectious Dis Clinic North Am. 2001;15(3):877-99.

Karoney MJ, Siika AM. Hepatitis C virus (HCV) infection in Africa: a review. Pan African Med J. 2013;14(1).

Aghakhani A, Banifazl M, Eslamifar A, Ahmadi F, Ramezani A. Viral hepatitis and HIV infection in hemodialysis patients. Hepat Mon. 2012;12:463-64.

Saha D, Agarwal SK. Hepatitis and HIV infection during haemodialysis. J Ind Med Assoc. 2001;99(4):194-9.

Kane M. Global programme for control of hepatitis B infection. Vaccine 1995;13:S47-9.

Al-Mahtab M, Rahman S, Karim F, Foster G, Solaiman S. Epidemiology of hepatitis C virus in Bangladeshi general population. Bangabandhu Sheikh Mujib Med Univ J. 2009;2(1):14-7.

Bhaumik P, Debnath K. Prevalence of hepatitis B and C among haemodialysis patients of Tripura, India. Euro J Hepato-Gastroentero. 2012;2(1):10-3.

Ahmed H, Rahman H, Rashid HU. Prevalence of Hepatitis C virus in maintenance hemodialysis patients-a prospective study. Bangladesh Renal J. 2003; 22(2):39-43.

Hossain RM, Iqbal MM, Rahman ZF, Sultana R, Rahman MH, Islam MN, et al. Hepatitis B and Hepatitis C virus infection among end stage renal disease patients on maintenance hemodialysis, their family members and dialysis staffs-a prevalence study. BIRDEM Med J. 2018;8(1):42-6.

Rahman AM. Hepatitis B and Hepatitis C Virus Infection in Haemodialysis Patients. J Armed Forces Med Coll Bangladesh. 2014;10(2):66-70.

Perumal A, Ratnam PV, Nair S, Anitha P, Illangovan V, Kanungo R. Seroprevalence of hepatitis B and C in patients on hemodialysis and their antibody response to hepatitis B vaccination. J Current Res Sci Med. 2016;2(1):20.

Malhotra R, Soin D, Grover P, Galhotra S, Khutan H, Kaur N. Hepatitis B virus and hepatitis C virus co-infection in hemodialysis patients:a retrospective study from a tertiary care hospital of North India. J Natural Sci Biol Med. 2016;7(1):72.

Chawla NS, Sajiv CT, Pawar G, Pawar B. Hepatitis B and C virus infections associated with renal replacement therapy in patients with end stage renal disease in a tertiary care hospital in India–prevalence, risk factors and outcome. Ind J Nephrol. 2005;15(4):205-13.

Agarwal SK, Dash SC, Irshad M. Hepatitis C virus infection during haemodialysis in India. J Assoc Phys Ind. 1999;47(12):1139-43.